Answers are grounded in this paper and cite their sources.
Background: The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), which was said to have emerged from a livestock market in Wuhan, China in December 2019. The objective of this study was to determine the predictors and willingness of patients to accept the COVID-19 vaccine.Methods: This survey was carried out at the federal medical centre, Yenagoa between 4t January and 15 February 2021. It was a descriptive cross-sectional study. The study population consisted of 1,000 consecutive patients that presented to the various out-patients departments of the hospital. Written informed consent was obtained. Data collected with a predesigned questionnaire were analysed using statistical software (SPSS for windows® version 23, SPSS Inc, Chicago, USA).Results: Out of 1,000 participants, only 246 (24.6%) were willing to receive the COVID-19 vaccine. About 2 in every 5 participants were unwilling to take the vaccine due to trust issues. Lack of trust in the manufacturers and government were the reasons given by 43.4% and 41.8% of participants, respectively. All sociodemographic factors were significant predictors of willingness to receive COVID-19 vaccine. The male participants (OR=2.34; p=001) were 2 times more willing than women to receive COVID-19 vaccine.Conclusions: The willingness to accept COVID-19 vaccine is low here. The highest predictor of willingness to accept the vaccine was the male gender and this is quite significant in our environment where decision-making in the family lies mostly on the man.
No takes yet. Share an insight, caveat, or question.
Allagoa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: